Bernard, E., Nannya, Y., Hasserjian, R., Boultwood, J., & Pellagatti, A. (2020). Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes. Springer Nature.
Cita Chicago (17th ed.)Bernard, E., Y. Nannya, RP Hasserjian, J. Boultwood, i A. Pellagatti. Implications of TP53 Allelic State for Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes. Springer Nature, 2020.
Cita MLA (9th ed.)Bernard, E., et al. Implications of TP53 Allelic State for Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes. Springer Nature, 2020.
Atenció: Aquestes cites poden no estar 100% correctes.